Literature DB >> 8730256

Biochemical aspects of Helicobacter pylori colonization of the human gastric mucosa.

T Wadström1, S Hirmo, T Borén.   

Abstract

Unlike Helicobacter felis and other Helicobacter species of animal origin, Helicobacter pylori colonizes the lower gastric mucin layer of the stomach and adheres to human gastric epithelial cells. It is still an open question if H. pylori can interact with specific glycoconjugates in the gastric mucin layer. It is possible that colonization of the oral cavity is a first step of a complex infectious process. Most likely resting or slow growing cells of H. pylori interact with Lewis blood group substances in the gastric mucin layer and on the epithelium. This initial colonization is probably followed by binding to specific cell surface glycoconjugates (glycoproteins and glycolipids such as GM3) and specific sialylated or highly sulphated molecules such as cell surface sulphatides and heparan sulphate. H. pylori may also bind to specific phospholipid molecules such as phosphatidylethanolamine on the gastric cells. The adhesion process of certain strains can stimulate 'close' cell adhesion including pedestal formation similar to the phenomenon typical for a special class of enterovirulent Escherichia coli called attaching effacing E. coli. After gastric cell destruction by ammonia and H. pylori toxins (such as the vacuolating toxin) H. pylori may colonize the extracellular matrix (ECM). This phenomenon seems to include binding of cell surface sialic acid specific haemagglutinin to one ECM component, i.e. laminin. It is also likely that H. pylori may use similar events to penetrate intercellular junctions of gastric epithelial cells. These adhesion-penetration phenomena also involve coating of the microbe with host proteins to escape the host immune system and initiate a chronic lifelong infection process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730256     DOI: 10.1046/j.1365-2036.1996.22164002.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Pathogenic diversity of Helicobacter pylori.

Authors:  F Mégraud
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

Review 2.  Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process.

Authors:  J Daniel Dubreuil; Giuseppe Del Giudice; Rino Rappuoli
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

3.  Lectin histochemistry of the gastric mucosa in normal and Helicobacter pylori infected guinea-pigs.

Authors:  M Lueth; E Sturegård; H Sjunnesson; T Wadström; U Schumacher
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

4.  Cloning and expression and immunogenicity of Helicobacter pylori BabA2 gene.

Authors:  Yang Bai; Ya-Li Zhang; Ye Chen; Jian-Feng Jin; Zhao-Shan Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

Review 5.  Does Helicobacter pylori infection contribute to gastroesophageal reflux disease?

Authors:  S J Spechler
Journal:  Yale J Biol Med       Date:  1998 Mar-Apr

6.  Anti-Helicobacter pylori effect of CaG-NANA, a new sialic acid derivative.

Authors:  Yun-Hee Rhee; Hyun-Jeong Ku; Hye-Ji Noh; Hyang-Hyun Cho; Hee-Kyong Kim; Jin-Chul Ahn
Journal:  World J Gastrointest Pathophysiol       Date:  2016-11-15

Review 7.  Sialic acids in molecular and cellular interactions.

Authors:  S Kelm; R Schauer
Journal:  Int Rev Cytol       Date:  1997

8.  Inhibition of Helicobacter pylori sialic acid-specific haemagglutination by human gastrointestinal mucins and milk glycoproteins.

Authors:  S Hirmo; S Kelm; M Iwersen; K Hotta; Y Goso; K Ishihara; T Suguri; M Morita; T Wadström; R Schauer
Journal:  FEMS Immunol Med Microbiol       Date:  1998-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.